# Thymoquinone prevents valproic acid-induced hepatotoxicity via modulation of cytochrome P450, PPARs, and apoptotic pathways

**Authors:** Sebile Azırak, Sedat Bilgiç, Deniz Taştemir Korkmaz, İlkay Armağan, Mehmet Özer Kaya

PMC · DOI: 10.22038/ijbms.2025.85190.18407 · Iranian Journal of Basic Medical Sciences · 2025-01-01

## TL;DR

Thymoquinone protects the liver from valproic acid toxicity by reducing harmful gene activity and oxidative stress.

## Contribution

This study demonstrates TQ's hepatoprotective effects through modulation of CYP450, PPARs, and apoptotic pathways disrupted by VPA.

## Key findings

- TQ reduced expression of p53, CYP2B1, CYP2B2, PPARα, and PPARγ genes in VPA-treated rats.
- TQ increased Bcl-2 gene expression and improved liver function markers like ALT, AST, and HDL.
- TQ decreased oxidative stress markers CAS-3 and NOX-4 and improved liver weight.

## Abstract

Thymoquinone (TQ) is the main bioactive component of Nigella sativa L. and has anti-oxidant, anti-hepatotoxic, anti-cancer, anti-hypertensive, hypoglycemic, anti-inflammatory, and lipid-lowering properties. In this study, we investigated the protective properties of TQ on the cytochrome P450 enzyme system, peroxisome proliferator-activated receptors, and gene expressions involved in apoptosis, which are disrupted by valproic acid (VPA).

The rats were put into control, VPA, and VPA+TQ groups. The weight of the body and liver were recorded. Liver tissue samples were evaluated for gene expressions (Bcl-2, p53, CYP2B1, CYP2B2, PPARα, and PPARγ), histopatology, and immunohistochemistry (CAS-3 and NOX-4). Additionally, serum was used to measure liver function parameters (ALT, AST, LDH, LDL, and HDL).

The VPA+TQ group had significantly lower expression of p53 (P<0.05), CYP2B1 (P<0.05), CYP2B2 (P<0.05), PPARα (P<0.05), and PPARγ (P<0.05) genes compared to the VPA groups, while Bcl-2 (P<0.05) gene expression increased. TQ decreased CAS-3 and NOX-4 levels. Also, TQ reduced ALT (P<0.05), AST (P<0.05), LDL (P<0.01), total bilirubin (P<0.05), and LDH (P<0.05) enzyme activity while increasing HDL (P<0.0001). TQ treatment improved fresh liver weight considerably (P<0.0001).

TQ substantially protects liver tissue by modifying gene expression, lowering oxidative stress, and increasing liver function. It significantly counteracts VPA’s toxic effects, demonstrating its promise as a hepatoprotective agent in avoiding liver damage.

## Linked entities

- **Genes:** BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], TP53 (tumor protein p53) [NCBI Gene 7157], Cyp2b1 (cytochrome P450, family 2, subfamily b, polypeptide 1) [NCBI Gene 24300], Cyp2b2 (cytochrome P450, family 2, subfamily b, polypeptide 2) [NCBI Gene 361523], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468]
- **Chemicals:** Thymoquinone (PubChem CID 10281), valproic acid (PubChem CID 3121)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, p53-ps (Wistar clone pR53P1 p53 pseudogene) [NCBI Gene 301300], Cyp2b1 (cytochrome P450, family 2, subfamily b, polypeptide 1) [NCBI Gene 24300] {aka Cyp2b-1, Cypbe}, Cyp2b2 (cytochrome P450, family 2, subfamily b, polypeptide 2) [NCBI Gene 361523] {aka CYPIIB2, Cype}, Cyp2g1 (cytochrome P450, family 2, subfamily g, polypeptide 1) [NCBI Gene 25251] {aka CYPIIG1, P-450olf1, P450-OLF1}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 25747] {aka PPAR}, Pparg (peroxisome proliferator-activated receptor gamma) [NCBI Gene 25664] {aka PPARgamma2}, Nox4 (NADPH oxidase 4) [NCBI Gene 85431]
- **Diseases:** inflammatory (MESH:D007249), cancer (MESH:D009369), hypertensive (MESH:D006973), liver damage (MESH:D056486)
- **Chemicals:** VPA (MESH:D014635), bilirubin (MESH:D001663), lipid (MESH:D008055), TQ (MESH:C003466)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Nigella sativa (black-caraway, species) [taxon 555479]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12279735/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12279735/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12279735/full.md

---
Source: https://tomesphere.com/paper/PMC12279735